@inproceedings{oai:repo.qst.go.jp:00054384,
 author = {Kamada, Tadashi and Imai, Reiko and Serizawa, Itsuko and Kagei, Kenji and Tsuji, Hiroshi and Yanagi, Takeshi and Ishikawa, Hitoshi and Tsujii, Hirohiko and 鎌田 正 and 今井 礼子 and 芹澤 慈子 and 影井 兼司 and 辻 比呂志 and 柳 剛 and 石川 仁 and 辻井 博彦},
 book = {Proceedings of NIRS-MD Anderson Symposium on Clinical Issues for Particle Therapy},
 issue = {210},
 month = {Mar},
 note = {The Heavy Ion Medical Accelerator in Chiba (HIMAC) is the world's first heavy ion accelerator complex dedicated to medical use in a hospital environment. Heavy ions have superior depth-dose distribution and greater cell-killing capability. In June 1996, clinical research for the treatment of bone and soft tissue sarcomas was begun using carbon ions generated by the HIMAC. As of August 2007, a total of more than 350 patients with bone and soft tissue sarcoma were enrolled onto the clinical trials. Most of the patients had locally advanced and/or medically inoperable tumors. The clinical trial revealed that carbon ion radiotherapy provided definite local control and offered a survival advantage without unacceptable morbidity in bone and soft tissue sarcomas that were hard to cure with other modality.},
 pages = {24--29},
 publisher = {[National Institute of Radiological Sciences]},
 title = {Carbon ion radiotherapy in bone and soft tissue sarcomas},
 volume = {NIRS-M},
 year = {2008}
}